Support The Moscow Times!

Luxoft Files for IPO of up to $80M

IT firm IBS Group's software development unit Luxoft Holding has received a good reaction from investors on the roadshow for its upcoming New York Stock Exchange offering, the CEO of IBS said Saturday.

Switzerland-based Luxoft filed with U.S. regulators in May to raise up to $80 million in an initial public offering of its common stock.

"IBS is undervalued since it is split into two assets — IBS and Luxoft," said IBS president and CEO Anatoly Karachinsky in an interview. "The main reason [for the IPO] is to identify the true value of the company."

Karachinsky said the spinoff was logical as the two businesses operated in different markets.

"IBS operates in emerging markets, Luxoft in more mature markets," he said. "They have different investor groups interested in the companies."

Luxoft provides software development and support, product engineering and testing, and technology consulting services. It counts Deutsche Bank, UBS and Boeing among its customers.

In June, it said 4.1 million shares would be priced at $16 to $18 a share. Proceeds of the offering will be used for working capital and other general corporate purposes, the prospectus said.

"The deal will happen very fast," Karachinsky said. "We are now doing the roadshow. So far, [investor reaction] is very good."

The company, which plans to list its common stock under the symbol "LXFT," listed UBS, Credit Suisse and JP Morgan among the underwriters to its offering.

Read more

Independent journalism isn’t dead. You can help keep it alive.

As the only remaining independent, English-language news source reporting from Russia, The Moscow Times plays a critical role in connecting Russia to the world.

Editorial decisions are made entirely by journalists in our newsroom, who adhere to the highest ethical standards. We fearlessly cover issues that are often considered off-limits or taboo in Russia, from domestic violence and LGBT issues to the climate crisis and a secretive nuclear blast that exposed unknowing doctors to radiation.

Please consider making a one-time donation — or better still a recurring donation — to The Moscow Times to help us continue producing vital, high-quality journalism about the world's largest country.